Abstract
Whereas antihistamines are generally known for their sedative side effects, this review shows that several studies also found mild stimulating effects on performance for the H1-antagonists terfenadine, ebastine, fexofenadine and desloratadine. These stimulating effects were mostly demonstrated in tasks involving high levels of attention, e.g. divided attention tasks, vigilance tasks and driving tasks. The stimulating effects of these antihistamines were often dependent of the given dose; however the relation was not always linear. The mechanism responsible for the stimulating effects of these four antihistamines is still unclear, though it is hypothesized that it involves other neurotransmitters like dopamine and GABA, or that it acts through the H3 histamine receptor. Further research is needed to clarify the ambiguous role of histamine in processes of arousal. In addition, it would be useful to determine whether terfenadine, ebastine, fexofenadine and desloratadine can return allergic patients performance back to their preclinical level.
Keywords: Antihistamine, attention, desloratadine, dopamine, ebastine, fexofenadine, GABA, H3 receptor, performance, stimulant
Current Pharmaceutical Design
Title: Stimulating Effects of H1-Antagonists
Volume: 12 Issue: 20
Author(s): Eef L. Theunissen, Annemiek Vermeeren, Eric F.P.M. Vuurman and Johannes G. Ramaekers
Affiliation:
Keywords: Antihistamine, attention, desloratadine, dopamine, ebastine, fexofenadine, GABA, H3 receptor, performance, stimulant
Abstract: Whereas antihistamines are generally known for their sedative side effects, this review shows that several studies also found mild stimulating effects on performance for the H1-antagonists terfenadine, ebastine, fexofenadine and desloratadine. These stimulating effects were mostly demonstrated in tasks involving high levels of attention, e.g. divided attention tasks, vigilance tasks and driving tasks. The stimulating effects of these antihistamines were often dependent of the given dose; however the relation was not always linear. The mechanism responsible for the stimulating effects of these four antihistamines is still unclear, though it is hypothesized that it involves other neurotransmitters like dopamine and GABA, or that it acts through the H3 histamine receptor. Further research is needed to clarify the ambiguous role of histamine in processes of arousal. In addition, it would be useful to determine whether terfenadine, ebastine, fexofenadine and desloratadine can return allergic patients performance back to their preclinical level.
Export Options
About this article
Cite this article as:
Theunissen L. Eef, Vermeeren Annemiek, Vuurman F.P.M. Eric and Ramaekers G. Johannes, Stimulating Effects of H1-Antagonists, Current Pharmaceutical Design 2006; 12 (20) . https://dx.doi.org/10.2174/138161206777698800
DOI https://dx.doi.org/10.2174/138161206777698800 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry Atypical Neuroleptic Malignant Syndrome or Serotonin Toxicity Associated with Atypical Antipsychotics?
Current Drug Safety An Overview on the Search for Schizophrenia Biomarkers
CNS & Neurological Disorders - Drug Targets Microglia-Neuron Interaction in Inflammatory and Degenerative Diseases: Role of Cholinergic and Noradrenergic Systems
CNS & Neurological Disorders - Drug Targets Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging
Current Topics in Medicinal Chemistry PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract
Current Molecular Pharmacology Animal Models for Investigating Benign Essential Blepharospasm
Current Neuropharmacology Near Infrared Optical Technologies to Illuminate the Status of the Neonatal Brain
Current Pediatric Reviews Neural Correlates of Schizotypal Personality Disorder: A Systematic Review of Neuroimaging and EEG Studies
Current Medical Imaging Adolescent HIV-1 Transgenic Rats: Evidence for Dopaminergic Alterations in Behavior and Neurochemistry Revealed by Methamphetamine Challenge
Current HIV Research Opportunities for Photoacoustic-Guided Drug Delivery
Current Drug Targets Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature
Current Rheumatology Reviews Transcranial Direct Current Stimulation - An Adjuvant Tool for the Treatment of Neuropsychiatric Diseases?
Current Psychiatry Reviews Physical Activity Level and Motor Aptitude: Motor Domains and Identification Capacity of Brazilian Insufficiently Active Older Adults
Current Aging Science The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
Current Drug Targets Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy
Current Drug Targets Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review
Current Clinical Pharmacology Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review
Current Pharmaceutical Biotechnology